Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

IGILUC 2019 /
Emerging role of radioembolization for hepatocellular carcinoma

18th - 19th Apr 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.05.19
Views: 447

Prof Riad Salem - Northwestern University, Chicago, USA

Prof Riad Salem speaks to ecancer at the 2019 International Gastrointestinal, Liver and Uro-Oncology Conference (IGILUC) in Cairo about the use of radioembolization for patients with hepatocellular carcinoma.

Prof Salem discusses the role of this emerging technique at multiple stages of the disease - including early, intermediate and advanced disease.

He also highlights how the use of this treatment could be incorporated into new paradigms - including the acceleration of yttrium-90, which would minimise the need for multiple procedures. Advances in this area also include the introduction of 'same day radioembolization'.

Prof Salem also mentions the exciting possibility of combining yttrium-90 with systemic therapies including immunotherapy - which are ideas that will require additional research in the future.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation